Ozempic and Wegovy Lawsuits
Harding Mazzotti, LLP is investigating cases where individuals have suffered from:
- Gastroparesis/stomach paralysis
- Intestinal obstruction
- Deep vein thrombosis
- Pulmonary embolism
after using the diabetes and weight loss drugs Ozempic and Wegovy.
Contact our Wegovy and Ozempic lawyers today.
About Ozempic and Wegovy
The drug Ozempic was developed by Novo Nordisk and approved to help control high blood sugar in patients with Type 2 diabetes in 2017. The drug includes the ingredient semaglutide, a glucagon-like peptide-1. Glucagon-like peptide 1 encourages the release of insulin from the pancreatic beta cells, increases the volume of pancreatic beta cells, and reduces the release of glucagon. It also slows the passage of food through the stomach. Soon after Ozempic entered the market, it was observed that the drug caused appetite suppression often resulting in weight loss. With this knowledge manufacturer Novo Nordisk then developed Wegovy, a higher dose version of Ozempic, which was approved by the FDA in 2021 to treat patients with weight gain and obesity. Both Ozempic and Wegovy are administered by the patient via subcutaneous injection.
Gastroparesis and Intestinal Blockage Linked to Ozempic and Wegovy
In 2023, the FDA reported that complaints submitted through the FDA Adverse Event Reporting System (FAERS) point to potential safety issues with these medications. This includes the life-threatening risk of intestinal obstruction.
Intestinal obstructions are more likely to occur in people taking semaglutide medications like Ozempic and Wegovy , according to published studies. Signs and symptoms of intestinal blockage (also known as an obstruction) may include:
- Abdominal pain, cramping and swelling
- Inability to pass gas
- Loud stomach sounds
Patients with gastroparesis, often known as stomach paralysis, have also recently been reported by doctors. Gastroparesis causes food to remain in the stomach for an excessive amount of time, or for the stomach to not empty properly, because the nerves and muscles have been stopped from functioning normally. The following are typical signs of gastroparesis:
- Acid Reflux/Indigestion
- Bloated stomach
- Feeling full very quickly or after eating very little
- Abdominal pain
- Loss of appetite
Lawsuits allege that Novo Nordisk neglected to warn of intestinal blockages, stomach paralysis or pancreatic cancer.
Contact a Wegovy and Ozempic Lawyer Today
If you or a loved one used the drugs Wegovy or Ozempic and experienced gastroparesis, intestinal obstruction, deep vein thrombosis, pulmonary embolism, contact the Ozempic and Wegovy injury lawyers at Harding Mazzotti, LLP today for a free case evaluation. Click, Chat, or call 1800LAW1010 24/7 for a free consultation.